Back
Novartis AG Vs. Novo Nordisk A/S Industry Stock Comparison
Buy
75
NVS
Novartis AG
Last Price:
97.87
Seasonality Move:
2.96%
Buy
60
NVO
Novo Nordisk A/S
Last Price:
127.44
Seasonality Move:
5.12%
Buy
75
Novartis AG (NVS)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
- The current Novartis AG [NVS] share price is $99.06. The Score for NVS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- NVS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
Novo Nordisk A/S (NVO)
is a Buy
Is Novo Nordisk A/S a Buy, Sell or Hold?
- The current Novo Nordisk A/S [NVO] share price is $125.79. The Score for NVO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- NVO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NVS Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $99.06
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVS is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVO Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $125.79
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 61.98 | Buy |
| Chaikin Money Flow: | 1479455 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (93.82 - 96.92) | Buy |
| Bollinger Bands (100): | (95.85 - 104.69) | Sell |
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.29 | Sell |
| Relative Strength Index (14 RSI): | 50.05 | Buy |
| Chaikin Money Flow: | 3239942 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (124.1 - 128.28) | Sell |
| Bollinger Bands (100): | (104.71 - 128.11) | Buy |
NVS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 95.38 | Buy |
| 20-day SMA: | 95.25 | Buy |
| 50-day SMA: | 97.96 | Buy |
| 200-day SMA: | 99.77 | Sell |
| 8-day EMA: | 96.4 | Buy |
| 20-day EMA: | 95.9 | Buy |
| 50-day EMA: | 97.47 | Buy |
| 200-day EMA: | 98.41 | Buy |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 124.91 | Buy |
| 20-day SMA: | 125.48 | Buy |
| 50-day SMA: | 126.66 | Sell |
| 200-day SMA: | 104.75 | Buy |
| 8-day EMA: | 125.52 | Buy |
| 20-day EMA: | 125.76 | Buy |
| 50-day EMA: | 124.04 | Buy |
| 200-day EMA: | 107.19 | Buy |
Novartis AG Earnings Growth & NVS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.09 per share, an increase this year of $0.62 per share, and an increase next year of $0.50 per share.
Novo Nordisk A/S Earnings Growth & NVO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and an increase next year of $0.70 per share.
Novartis AG Technical Analysis
| Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk A/S Technical Analysis
| Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||